Familial Prostate Cancer

National Cancer Institute (NCI)200 enrolled

Overview

The purpose of this study is to identify affected individuals in families with prostate cancer and to use this information to identify genetic markers closely-linked to the disease gene.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Neoplastic Syndromes, Hereditary Prostatic Neoplasms

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Families will be identified with two or more first degree relatives affected with prostate cancer or with one male with prostate cancer that developed before age 55. Must have clinical evidence of prostate cancer in the family.

Locations (1)

National Cancer Institute (NCI)

Bethesda, Maryland, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.